ARTICLE | Distillery Therapeutics
Therapeutics: Voltage-dependent anion channel 1 (VDAC1)
February 25, 2016 8:00 AM UTC
Mouse studies suggest inhibiting VDAC1 could help treat diabetic neuropathy and Charcot-Marie-Tooth 1A (CMT1A) disease. In mouse models of diabetic neuropathy and CMT1A, a VDAC1 inhibitor tool compoun...